Osaic Holdings
GMAB icon

Osaic Holdings’s Genmab GMAB Stock Holding History

Osaic Holdings’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$73K Buy
2,656
+130
+5% +$3.46K ﹤0.01% 5196
2026
Q1 		$67.8K Buy
2,526
+1,290
+104% +$38.7K ﹤0.01% 4980
2025
Q4 		$38.1K Sell
1,236
-959
-44% -$29.9K ﹤0.01% 5424
2025
Q3 		$65K Buy
2,195
+592
+37% +$14.4K ﹤0.01% 5128
2025
Q2 		$33K Buy
1,603
+440
+38% +$9.03K ﹤0.01% 5333
2025
Q1 		$22.8K Sell
1,163
-1,288
-53% -$27K ﹤0.01% 5267
2024
Q4 		$51.1K Sell
2,451
-5,494
-69% -$121K ﹤0.01% 4685
2024
Q3 		$194K Buy
7,945
+716
+10% +$19.1K ﹤0.01% 3671
2024
Q2 		$182K Sell
7,229
-23,173
-76% -$657K ﹤0.01% 3644
2024
Q1 		$909K Buy
30,402
+1,988
+7% +$58.4K ﹤0.01% 2432
2023
Q4 		$904K Sell
28,414
-20,330
-42% -$638K ﹤0.01% 2619
2023
Q3 		$1.72M Buy
48,744
+22,213
+84% +$846K ﹤0.01% 2140
2023
Q2 		$1.01M Sell
26,531
-698
-3% -$27.8K ﹤0.01% 2516
2023
Q1 		$1.03M Sell
27,229
-4,906
-15% -$189K ﹤0.01% 2437
2022
Q4 		$1.36M Buy
32,135
+8,511
+36% +$351K ﹤0.01% 2069
2022
Q3 		$759K Buy
23,624
+6,106
+35% +$214K ﹤0.01% 2485
2022
Q2 		$569K Buy
17,518
+3,019
+21% +$97.8K ﹤0.01% 2798
2022
Q1 		$1.38M Sell
14,499
-1,962
-12% -$67.3K ﹤0.01% 2270
2021
Q4 		$651K Sell
16,461
-1,434
-8% -$59.8K ﹤0.01% 2799
2021
Q3 		$782K Buy
17,895
+3,656
+26% +$164K ﹤0.01% 2574
2021
Q2 		$583K Sell
14,239
-11,415
-44% -$441K ﹤0.01% 2856
2021
Q1 		$842K Sell
25,654
-4,629
-15% -$174K ﹤0.01% 2386
2020
Q4 		$1.23M Buy
30,283
+4,001
+15% +$150K ﹤0.01% 1850
2020
Q3 		$960K Buy
26,282
+8,499
+48% +$307K ﹤0.01% 1873
2020
Q2 		$603K Buy
17,783
+5,782
+48% +$158K ﹤0.01% 2175
2020
Q1 		$254K Buy
+12,001
New +$268K ﹤0.01% 2682

Other funds holding GMAB

PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Osaic Holdings's GMAB Position: Q2 2026 in Review

Osaic Holdings increased its Genmab (GMAB) stake by 5.1% in Q2 2026, buying an estimated $3.46K and bringing the position to 2,656 shares worth $73K. The position accounts for ﹤0.01% of the portfolio, ranked #5196.

Osaic Holdings first reported a position in GMAB in Q1 2020 and has held it in 26 quarters since. The position peaked at $1.72M in Q3 2023. 289 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • Osaic Holdings held 2,656 shares of Genmab worth $73K as of Q2 2026.
  • Osaic Holdings bought 130 Genmab shares in Q2 2026, an estimated $3.46K.
  • Genmab made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #5196 holding.
  • Osaic Holdings first reported a position in Genmab in Q1 2020 and has held it in 26 quarters since.
  • Osaic Holdings's Genmab position peaked at $1.72M in Q3 2023.
  • 289 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.